The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Pregnancy Risk Assessment Monitoring System (PRAMS) |
93.946 |
RFA-DP-21-001 |
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
93.393 |
PAR-20-136 |
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-006 |
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
93.393, 93.847 |
PAR-20-134 |
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) |
93.855 |
RFA-AI-20-028 |
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
93.393, 93.847 |
PAR-20-133 |
Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-019 |
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
93.113, 93.142, 93.143, 93.172, 93.213, 93.307, 93.393, 93.394, 93.395, 93.396, 93.399, 93.847, 93.855, 93.859, 93.865 |
PA-20-135 |
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed) |
93.846 |
RFA-AR-21-004 |
SBIR/STTR FY 2020 Phase II Release 2 |
81.049 |
DE-FOA-0002156 |
Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-015 |
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
93.394, 93.395 |
RFA-CA-20-033 |
Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-010 |
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) |
93.855 |
PAS-20-121 |
BJA FY 20 Supporting Small and Rural Law Enforcement Agency Body-Worn Camera Policy and Implementation Program |
16.835 |
BJA-2020-17011 |
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) |
93.173 |
PAR-20-127 |
Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) |
93.242, 93.855 |
RFA-AI-20-016 |
NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) |
93.846 |
RFA-AR-21-003 |
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) |
93.173 |
PAR-20-123 |
NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) |
93.865 |
PAR-20-126 |
Regional Food System Partnerships |
10.177 |
USDA-AMS-TM-RFSP-G-20-0009 |
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed |
93.876 |
PAR-20-124 |
Research Education Program Grants for CryoEM and CryoET Curriculum Development (R25 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-010 |
Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional) |
93.121, 93.213 |
RFA-AT-21-002 |
Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional) |
93.121, 93.213 |
RFA-AT-21-001 |
Strategic Trends Division Broad Agency Announcement (BAA) |
12.910 |
HDTRA1-20-S-0002BAA |
Rural Community Development Initiative |
10.446 |
USDA-RD-HCFP-RCDI-2020 |
Urological Epidemiology (UroEpi) Institutional Research Career Development Program (K12 - Independent Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-001 |
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) |
93.855 |
PAR-20-120 |
Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional) |
93.361 |
RFA-NR-20-002 |
MICRO-2020-02 |
59.046 |
SBA-OCAML-20-001 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-20-122 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-20-111 |
Section 108 Foreign Currency Program (FY2020) |
10.617 |
2020-08 |
BJA FY 20 National Community Courts Site-based and Training and Technical Assistance Initiative |
16.585 |
BJA-2020-17249 |
Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-003 |
Market Development Cooperator Program 2020 |
11.112 |
ITA-INA-OIE-2020-2006337 |
Women's Business Center - Initial Phase Grant |
59.043 |
OWBO-2020-04 |
National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed) |
93.275, 93.307, 93.865, 93.866 |
RFA-AG-21-008 |
Louisiana Conservation Delivery Technical Assistance, FY20 |
10.902 |
USDA-NRCS-LA-MULTI-20-GEN0010696 |
Search Results 5641-5680 of 22040 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 [Next] |